VIEMED HEALTHCARE INC (VMD)

CA92663R1055 - Common Stock

7.35  -0.31 (-4.05%)

Fundamental Rating

6

VMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 118 industry peers in the Health Care Providers & Services industry. VMD has an excellent profitability rating, but there are some minor concerns on its financial health. VMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes VMD very considerable for growth investing!



7

1. Profitability

1.1 Basic Checks

VMD had positive earnings in the past year.
In the past year VMD had a positive cash flow from operations.
Each year in the past 5 years VMD has been profitable.
In the past 5 years VMD always reported a positive cash flow from operatings.

1.2 Ratios

VMD has a Return On Assets of 6.62%. This is amongst the best in the industry. VMD outperforms 88.89% of its industry peers.
Looking at the Return On Equity, with a value of 9.00%, VMD is in the better half of the industry, outperforming 74.36% of the companies in the same industry.
VMD's Return On Invested Capital of 8.55% is amongst the best of the industry. VMD outperforms 84.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VMD is in line with the industry average of 8.48%.
The 3 year average ROIC (7.69%) for VMD is below the current ROIC(8.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.62%
ROE 9%
ROIC 8.55%
ROA(3y)6.54%
ROA(5y)11.58%
ROE(3y)8.33%
ROE(5y)16.6%
ROIC(3y)7.69%
ROIC(5y)10.69%

1.3 Margins

VMD has a better Profit Margin (5.60%) than 83.76% of its industry peers.
VMD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.19%, VMD belongs to the top of the industry, outperforming 80.34% of the companies in the same industry.
VMD's Operating Margin has declined in the last couple of years.
VMD has a Gross Margin of 61.63%. This is amongst the best in the industry. VMD outperforms 84.62% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.19%
PM (TTM) 5.6%
GM 61.63%
OM growth 3Y-24.03%
OM growth 5Y-12.35%
PM growth 3Y-38.44%
PM growth 5Y-17.59%
GM growth 3Y0.34%
GM growth 5Y-3.62%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VMD is destroying value.
The number of shares outstanding for VMD has been increased compared to 1 year ago.
Compared to 5 years ago, VMD has more shares outstanding
Compared to 1 year ago, VMD has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.62 indicates that VMD is not in any danger for bankruptcy at the moment.
VMD has a better Altman-Z score (6.62) than 93.16% of its industry peers.
VMD has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
VMD has a Debt to FCF ratio of 0.50. This is amongst the best in the industry. VMD outperforms 93.16% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that VMD is not too dependend on debt financing.
VMD's Debt to Equity ratio of 0.07 is amongst the best of the industry. VMD outperforms 80.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.5
Altman-Z 6.62
ROIC/WACC0.93
WACC9.17%

2.3 Liquidity

VMD has a Current Ratio of 1.19. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
VMD has a Current ratio (1.19) which is in line with its industry peers.
VMD has a Quick Ratio of 1.05. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.05, VMD is doing worse than 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.05

8

3. Growth

3.1 Past

VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.33%, which is quite impressive.
Measured over the past 5 years, VMD shows a small growth in Earnings Per Share. The EPS has been growing by 1.11% on average per year.
VMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.81%.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 23.19% on average per year.
EPS 1Y (TTM)73.33%
EPS 3Y-30.66%
EPS 5Y1.11%
EPS growth Q2Q50%
Revenue 1Y (TTM)31.81%
Revenue growth 3Y11.7%
Revenue growth 5Y23.19%
Revenue growth Q2Q35.27%

3.2 Future

The Earnings Per Share is expected to grow by 27.73% on average over the next years. This is a very strong growth
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.77% yearly.
EPS Next Y39.85%
EPS Next 2Y27.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.16%
Revenue Next 2Y15.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.27, the valuation of VMD can be described as expensive.
Based on the Price/Earnings ratio, VMD is valued a bit cheaper than 64.10% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.11, VMD is valued at the same level.
A Price/Forward Earnings ratio of 20.21 indicates a rather expensive valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued a bit cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.39. VMD is around the same levels.
Industry RankSector Rank
PE 28.27
Fwd PE 20.21

4.2 Price Multiples

VMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VMD is cheaper than 88.03% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, VMD is valued cheaply inside the industry as 82.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.92
EV/EBITDA 7.98

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
VMD's earnings are expected to grow with 27.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.71
PEG (5Y)25.37
EPS Next 2Y27.73%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VIEMED HEALTHCARE INC

NASDAQ:VMD (5/8/2024, 2:05:59 PM)

7.35

-0.31 (-4.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap285.33M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 28.27
Fwd PE 20.21
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.71
PEG (5Y)25.37
Profitability
Industry RankSector Rank
ROA 6.62%
ROE 9%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.19%
PM (TTM) 5.6%
GM 61.63%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.19
Quick Ratio 1.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)73.33%
EPS 3Y-30.66%
EPS 5Y
EPS growth Q2Q
EPS Next Y39.85%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.81%
Revenue growth 3Y11.7%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y